These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38036236)

  • 1. Cardioneuroablation for reflex asystolic syncope: Mid-term safety, efficacy, and patient's acceptance.
    Kulakowski P; Baran J; Sikorska A; Krynski T; Niedzwiedz M; Soszynska M; Piotrowski R
    Heart Rhythm; 2024 Mar; 21(3):282-291. PubMed ID: 38036236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R; Baran J; Sikorska A; Krynski T; Kulakowski P
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioneuroablation for pediatric patients with functional sinus node dysfunction and paroxysmal atrioventricular block.
    Choi NH; Hong J; Moak JP
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):221-229. PubMed ID: 38038245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioneuroablation changes the type of vasovagal response in patients with asystolic reflex syncope.
    Piotrowski R; Żuk A; Baran J; Sikorska A; Kryński T; Kułakowski P
    Auton Neurosci; 2021 Nov; 235():102838. PubMed ID: 34186273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioneuroablation for severe neurocardiogenic syncope.
    Santos Silva G; Fonseca P; Cardoso F; Almeida J; Ribeiro S; Oliveira M; Sanfins V; Gonçalves H; Pachon M JC; Barra S; Primo J; Lourenço A; Fontes-Carvalho R
    Rev Port Cardiol; 2023 Oct; 42(10):821-829. PubMed ID: 37268266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope.
    Joza J; Gustavo Bravosi da Rosa L; Alturki A; Anglesio V; Sanchez-Somonte P; Poletaev V; Bernier M; Verma A; Essebag V
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101360. PubMed ID: 38379634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study.
    Aksu T; Guler TE; Mutluer FO; Bozyel S; Golcuk SE; Yalin K
    J Interv Card Electrophysiol; 2019 Mar; 54(2):177-188. PubMed ID: 30054828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study.
    Brignole M; Arabia F; Ammirati F; Tomaino M; Quartieri F; Rafanelli M; Del Rosso A; Rita Vecchi M; Russo V; Gaggioli G;
    Europace; 2016 Sep; 18(9):1427-33. PubMed ID: 26612880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right anterior ganglionated plexus: The primary target of cardioneuroablation?
    Hu F; Zheng L; Liang E; Ding L; Wu L; Chen G; Fan X; Yao Y
    Heart Rhythm; 2019 Oct; 16(10):1545-1551. PubMed ID: 31330187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.
    Vandenberk B; Morillo CA; Sheldon RS; Chew DS; Aksu T; Raj SR
    Heart Rhythm; 2021 Dec; 18(12):2160-2166. PubMed ID: 34419666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate distribution in paced and non-paced patients with severe recurrent reflex syncope and tilt-induced asystole: Findings from the BIOSync CLS study.
    Russo V; Anguera I; de Lange FJ; De Ruvo E; Taieb J; Zardini M; Nigro G; Giacopelli D; Gargaro A; Brignole M
    Int J Cardiol; 2021 Jul; 335():52-54. PubMed ID: 33887343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioinhibitory syncope: from pathophysiology to treatment-should we think on cardioneuroablation?
    Garcia A; Marquez MF; Fierro EF; Baez JJ; Rockbrand LP; Gomez-Flores J
    J Interv Card Electrophysiol; 2020 Nov; 59(2):441-461. PubMed ID: 32377918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results.
    Pachon JC; Pachon EI; Cunha Pachon MZ; Lobo TJ; Pachon JC; Santillana TG
    Europace; 2011 Sep; 13(9):1231-42. PubMed ID: 21712276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.
    Penela D; Berruezo A; Roten L; Futyma P; Richter S; Falasconi G; Providencia R; Chun J
    Europace; 2024 May; 26(5):. PubMed ID: 38781099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioneuroablation for cardioinhibitory vasovagal syncope.
    John LA; Mullis A; Payne J; Tung R; Aksu T; Winterfield JR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1748-1753. PubMed ID: 33855779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of cardioneuroablation with and without extra-cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope.
    Pachon-M JC; Pachon-M EI; Pachon CTC; Santillana-P TG; Lobo TJ; Pachon-M JC; Higuti C; Zerpa-A JC; Pachon MZC; Ortencio FA; Osorio TG; Peixoto LA
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):641-650. PubMed ID: 38240356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent pacing versus cardioneuroablation for cardioinhibitory vasovagal syncope.
    Gopinathannair R; Olshansky B; Turagam MK; Gautam S; Futyma P; Akella K; Tanboga HI; Bozyel S; Yalin K; Padmanabhan D; Shenthar J; Lakkireddy D; Aksu T
    J Interv Card Electrophysiol; 2022 Dec; ():. PubMed ID: 36562915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.